These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 9519417)

  • 1. Diagnostic significance of prostate-specific antigen velocity at intermediate PSA serum levels in relation to the standard deviation of different test systems.
    Manseck A; Pilarsky C; Froschermaier S; Menschikowski M; Wirth MP
    Urol Int; 1998; 60(1):25-7. PubMed ID: 9519417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of three assays for total serum prostate-specific antigen and percentage of free prostate-specific antigen in predicting prostate histology.
    Roehrborn CG; Gregory A; McConnell JD; Sagalowsky AI; Wians FH
    Urology; 1996 Dec; 48(6A Suppl):23-32. PubMed ID: 8973696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of 'ultrasensitive' prostate-specific antigen assays in the detection of biochemical recurrence after radical prostatectomy.
    van Iersel MP; Thomas CM; Segers MF; Witjes WP; Debruyne FM; Oosterhof GO
    Br J Urol; 1996 Mar; 77(3):418-22. PubMed ID: 8814849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Early diagnosis of prostate carcinoma with reference to the density of prostate-specific antigen].
    Schmid HP; Ravery V; Toublanc M; Boccon-Gibod L
    Schweiz Med Wochenschr; 1996 Sep; 126(36):1530-5. PubMed ID: 8927956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methodological and clinical comparison of the ACS prostate-specific antigen assay and the Tandem-E prostate-specific antigen assay in prostate cancer.
    Schambeck CM; Schmeller N; Stieber P; Jansen HM; Pahl H; Schneider W; Fateh-Moghadam A
    Urology; 1995 Aug; 46(2):195-9. PubMed ID: 7542821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variability of repeated serum prostate-specific antigen (PSA) measurements within less than 90 days in a well-defined patient population.
    Roehrborn CG; Pickens GJ; Carmody T
    Urology; 1996 Jan; 47(1):59-66. PubMed ID: 8560664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges.
    Oesterling JE; Jacobsen SJ; Chute CG; Guess HA; Girman CJ; Panser LA; Lieber MM
    JAMA; 1993 Aug; 270(7):860-4. PubMed ID: 7688054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate specific antigen density of the transition zone for early detection of prostate cancer.
    Djavan B; Zlotta AR; Byttebier G; Shariat S; Omar M; Schulman CC; Marberger M
    J Urol; 1998 Aug; 160(2):411-8; discussion 418-9. PubMed ID: 9679889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The quotient of prostate-specific antigen and prostate volume. Improved differentiation between benign prostatic hyperplasia and locally circumscribed prostate cancer].
    Semjonow A; Hamm M; Rathert P
    Urologe A; 1993 May; 32(3):250-3. PubMed ID: 7685557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the "reflex range" and appropriate cutpoints for percent free prostate-specific antigen in 413 men referred for prostatic evaluation using the AxSYM system.
    Vashi AR; Wojno KJ; Henricks W; England BA; Vessella RL; Lange PH; Wright GL; Schellhammer PF; Weigand RA; Olson RM; Dowell BL; Borden KK; Oesterling JE
    Urology; 1997 Jan; 49(1):19-27. PubMed ID: 9000179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate-specific antigen: insufficient discrimination between benign prostatic hyperplasia and organ-confined prostate cancer.
    Wolff JM; Boeckmann W; Borchers H; Handt S; Reineke T; Jakse G
    Urol Int; 1996; 57(3):170-4. PubMed ID: 8912446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of free prostate-specific antigen (Hybritech Tandem-R) in symptomatic patients consulting the urologist.
    Hofer C; Sauerstein P; Wolter C; Scholz M; Hartung R; Breul J
    Urol Int; 2000; 64(1):18-23. PubMed ID: 10782027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-specific antigen density values among patients with symptomatic prostatic enlargement in Nigeria.
    Udeh EI; Nnabugwu II; Ozoemena FO; Ugwumba FO; Aderibigbe AS; Ohayi SR; Echetabu KN
    World J Surg Oncol; 2016 Jun; 14(1):174. PubMed ID: 27356753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor markers. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.
    Stamey TA; Ekman PE; Blankenstein MA; Cooper EH; Kontturi M; Lilja H; Oesterling JE; Stenman UH; Turkes A
    Scand J Urol Nephrol Suppl; 1994; 162():73-87; discussion 115-27. PubMed ID: 7529430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assay variability in serum prostate-specific antigen determination.
    Brawer MK; Daum P; Petteway JC; Wener MH
    Prostate; 1995 Jul; 27(1):1-6. PubMed ID: 7541527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abbott IMx evaluated for assay of prostate-specific antigen in serum.
    Dnistrian AM; Schwartz MK; Smith CA; Nisselbaum JS; Fair WR
    Clin Chem; 1992 Oct; 38(10):2140-2. PubMed ID: 1382898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum prostate specific antigen levels in men with benign prostatic hyperplasia and cancer of prostate.
    Amayo A; Obara W
    East Afr Med J; 2004 Jan; 81(1):22-6. PubMed ID: 15080511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current usefulness of free/total PSA ratio in the diagnosis of prostate cancer at an early stage.
    Pfister C; Basuyau JP;
    World J Urol; 2005 Sep; 23(4):236-42. PubMed ID: 16096832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraindividual variations of total and percent free serum prostatic-specific antigen levels in patients with normal digital rectal examination.
    Morote J; Raventós CX; Lorente JA; Enbabo G; López M; de Torres I
    Eur Urol; 1999 Aug; 36(2):111-5. PubMed ID: 10420031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free and total prostate-specific antigen in a screened population.
    Bangma CH; Kranse R; Blijenberg BG; Schröder FH
    Br J Urol; 1997 May; 79(5):756-62. PubMed ID: 9158515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.